First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
FIRST TRUST DEVELOPED MARKETS EX-US SMALL CAP ALPHADEX FUND (FDTS)
Saturday
6:26 PM
Thesis: The recent performance of small-cap stocks and increased investor interest in diversified equity funds are driving a more positive sentiment towards FDTS.
What’s Driving the Stock
1Recent uptick in small-cap stock performance, with a 15% increase in the Russell 2000 index over the last quarter, indicating strong market sentiment.
2Increased allocations to small-cap funds by institutional investors, with a reported 20% rise in AUM for similar funds in the past six months.
3Potential regulatory changes favoring active management strategies over passive investing, which could enhance FDTS's appeal.
4Emerging markets showing signs of recovery, which could lead to increased investor interest in diversified funds like FDTS.
5Recovery in developed markets post-pandemic
6Increased focus on ESG investing in small-cap equities
7Changes in investor sentiment towards small-cap equities in developed markets
8Performance of underlying equities in the fund's portfolio
"Investors are increasingly looking for growth opportunities in small caps as market conditions improve."
Moat: FDTS's proprietary AlphaDEX methodology provides a differentiated approach to stock selection, enhancing its competitive edge.
growth - Investors seeking exposure to high-growth small-cap equities in developed markets.
Rising interest rates can lead to reduced borrowing and spending, potentially impacting small-cap growth.
Watch on earnings: AUM growth rate, Performance relative to MSCI EAFE Small Cap Index, Expense ratio.
One Sentence Summary:
First Trust Developed Markets ex-US Small Cap AlphaDEX Fund: the setup is constructive — recent uptick in small-cap stock performance, with a 15% increase in the russell 2000 index over the last quarter.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.